At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Study of Biomarkers in Hemophilic Arthropathy

Clinical Trial Title: 
Expression of biomarkers in hemophilic arthropathy: Repository of surgical tissue samples and biomarkers in patients with hemophilia.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Narine Hakobyan, PhD
Clinical Trial Protocol Description: 

Evaluating long term changes in molecules in hemophilia joints.

  1. Approximately two teaspoons (10 ml) of blood drawn from the arm.
  2. One to two teaspoons (5-10 ml) of synovial fluid drawn from the joint right before starting your regular surgical procedure. Synovial fluid is a thick, sticky lubricant present in the joint space between bones.
  3. Three to four small (2-3 mm / 0.08-0.12 inches) synovial tissue samples taken before the removal of scar tissue in the joint as part of the management in the case of a hemophilic joint or fixing the tear in subjects with joint trauma.
Clinical Trial Eligibility Criteria: 

To inquire about your eligibility, please call the contact number provided.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Contact Phone: 
(312) 942-3034
Contact Name: 
Narine Hakobyan, PhD